AGEN (STOCKS)
Agenus Inc.
$4.160000
+0.200000 (+5.05%)
Prev close: $3.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Garo H. Armen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $159.55M
- Employees
- 316
- P/E (TTM)
- -10.68
- P/B (TTM)
- -0.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.31 | $-1.07 | +0.7634 | +71.05% |
|
Sep 2025 (Q3)
|
$1.94 | $2.02 | -0.0796 | -3.94% |
|
Jun 2025 (Q2)
|
$-1.00 | $1.38 | -2.3804 | -172.44% |
|
Mar 2025 (Q1)
|
$-1.03 | $-1.69 | +0.6581 | +38.98% |
Financial Statements
| Revenues | $114.20M |
| Benefits Costs and Expenses | $117.28M |
| Cost Of Revenue | $1.02M |
| Costs And Expenses | $117.28M |
| Gross Profit | $113.17M |
| Nonoperating Income/Loss | -$2.22M |
| Operating Expenses | $133.34M |
| Depreciation and Amortization | $10.00M |
| Research and Development | $79.34M |
| Other Operating Expenses | $44.01M |
| Operating Income/Loss | -$20.17M |
| Income/Loss Before Equity Method Investments | $23.26M |
| Income/Loss From Continuing Operations After Tax | -$3.08M |
| Income/Loss From Continuing Operations Before Tax | -$3.08M |
| Income/Loss From Equity Method Investments | -$26.35M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$3.08M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$3.20M |
| Net Income/Loss Attributable To Parent | -$101.00K |
| Net Income/Loss Available To Common Stockholders, Basic | -$101.00K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $0.00 |
| Diluted Earnings Per Share | $0.00 |
| Basic Average Shares | 29,734,000 |
| Diluted Average Shares | 29,734,000 |
| Assets | $226.80M |
| Current Assets | $133.44M |
| Prepaid Expenses | $785.00K |
| Other Current Assets | $132.65M |
| Noncurrent Assets | $93.36M |
| Fixed Assets | $15.47M |
| Intangible Assets | $3.04M |
| Other Non-current Assets | $74.86M |
| Liabilities | $504.66M |
| Current Liabilities | $323.49M |
| Accounts Payable | $82.99M |
| Other Current Liabilities | $240.50M |
| Noncurrent Liabilities | $181.17M |
| Long-term Debt | $44.66M |
| Other Non-current Liabilities | $136.52M |
| Equity | -$277.86M |
| Equity Attributable To Noncontrolling Interest | -$6.75M |
| Equity Attributable To Parent | -$271.11M |
| Liabilities And Equity | $226.80M |
| Net Cash Flow From Operating Activities | -$77.20M |
| Net Cash Flow From Operating Activities, Continuing | -$77.20M |
| Net Cash Flow From Investing Activities | $1.19M |
| Net Cash Flow From Investing Activities, Continuing | $1.19M |
| Net Cash Flow From Financing Activities | $36.59M |
| Net Cash Flow From Financing Activities, Continuing | $36.59M |
| Net Cash Flow | -$39.41M |
| Net Cash Flow, Continuing | -$39.41M |
| Other Comprehensive Income/Loss | $959.00K |